School of Medicine, University of California, Davis, Sacramento, CA, USA.
Department of Dermatology, University of California, Davis, 3301 C Street, Suite 1400, Sacramento, CA, 95816, USA.
Am J Clin Dermatol. 2018 Apr;19(2):139-144. doi: 10.1007/s40257-017-0321-x.
Acne vulgaris is a chronic inflammatory skin disease that can lead to permanent scarring. Although grading scales exist for acne scarring, there are many limitations, and there is still a need for a well validated gold standard scale for use in clinical practice or research trials. An objective measure of scar severity should be a component of global acne severity evaluations. This manuscript reviews currently available acne scar grading modalities: lesion counting; subjective self-assessment; Acne Scar Rating Scale (ASRS); evaluator-based qualitative and quantitative scarring grading systems; Echelle d'Evaluation Clinique des Cicatrices d'acne (ECCA); Global Scale for Acne Scar Severity (SCAR-S); and imaging. Despite the varying tools, most of the currently available scales do not account for scar color, depth, or change over time. A new, validated scale is needed that would allow for a more objective and accurate assessment of scar progression over time to assist with effective treatment and research.
寻常痤疮是一种慢性炎症性皮肤病,可导致永久性瘢痕。虽然存在痤疮瘢痕的分级量表,但存在许多局限性,仍然需要一种经过充分验证的金标准量表用于临床实践或研究试验。瘢痕严重程度的客观测量应该是整体痤疮严重程度评估的一个组成部分。本文综述了目前可用的痤疮瘢痕分级方式:皮损计数;主观自我评价;痤疮瘢痕评分量表(ASRS);基于评估者的定性和定量瘢痕分级系统;痤疮瘢痕临床评估量表(ECCA);痤疮瘢痕严重程度全球量表(SCAR-S);以及成像。尽管工具各不相同,但目前大多数可用的量表都没有考虑到瘢痕的颜色、深度或随时间的变化。需要一种新的、经过验证的量表,以便更客观、更准确地评估瘢痕随时间的进展,从而有助于有效的治疗和研究。
Am J Clin Dermatol. 2018-4
J Eur Acad Dermatol Venereol. 2020-12
Cell Death Discov. 2024-10-29
J Cosmet Dermatol. 2025-1
Am J Clin Dermatol. 2024-9
J Pharm Bioallied Sci. 2024-4
Burns Trauma. 2024-4-5
Medicine (Baltimore). 2024-3-15